Biomarkers refer to genes, molecules or certain characteristics enabling to evaluate or measure pharmacologic response to therapeutic treatment, or various pathogenic or biological processes. Categorized by their utilization in different medical procedures, biomarkers facilitate decision-taking in early clinical drug development, thus helping to detect a patient’s health state. Oncology belongs within the major diseases where biomarkers are widely used.
Supported by novel product’s introductions, fresh market entrants, as well as M&As and other related activities, the world Biomarkers Market is evolving at a colossal tempo, set to be ultimately valued at just over EUR 26 billion by end-2018. Novel technologies exploited for biomarker discovery are the foremost contributors to the Biomarkers sector. North America heads the market as the most speedily growing geographic area. Major Biomarkers Market participants encompass, among others, Abbot Laboratories, Affymetrix, Agilent, Epigenomics, Celera, GE Healthcare, and DiagnoCure.
The research reports under this MarketPublishers’ Catalogue delve deep into the Biomarkers Market and its major submarkets – discovery technologies, services market, application market, and various indications. Covering various geographies, the research reports identify and examine the principal trends, opportunities, and the factors propelling or clogging the market growth. The competitive landscape with comprehensive profiles of numerous players in the global Biomarkers Industry, forecasts throwing light on the market’s future are provided in the research reports too.
Publications found:
105
Sort by:
Competitor Analysis Antibody Therapy of Inflammatory and Autoimmune Diseases
US$ 1,184.00
Product description The present Competitive Intelligence Report about Antibody Therapy of Inflammatory and Autoimmune Diseases provides a competitor evaluation in the field of antibody therapeutics used or being developed for treatment of rheumatoid arthritis, psoriasis, Crohn’s disease, ulcerative colitis ...
December 2010
172 pages
Global Monoclonal Antibody Market Analysis
US$ 1,200.00
Single User PDF Format: US$ 1,200.00
Multi-User License: US$ 1,600.00
Hard Copy: US$ 1,300.00
CD-ROM: US$ 1,300.00 Considered as an indispensable tool in the clinical and biotechnology...
November 2010
80 pages
Antibody Pipeline Database: 1-Year Subscription
US$ 1,638.00
... numerical order, e.g. for phase, product category or company name. Sample screenshots illustrate the database. Purchase of the subscription provides a 1-year online access to the data of the Antibody Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase. ...
November 2010
-
